365 related articles for article (PubMed ID: 31010449)
1. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
[TBL] [Abstract][Full Text] [Related]
2. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial.
Schäfer I; Chuey-Ferrer L; Hofmann A; Lieberman P; Mainusch G; Lotzin A
BMC Psychiatry; 2017 Mar; 17(1):95. PubMed ID: 28302084
[TBL] [Abstract][Full Text] [Related]
4. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
[TBL] [Abstract][Full Text] [Related]
5. Comparing Exposure- and Coping Skills-Based Treatments on Trauma-Related Guilt in Veterans With Co-Occurring Alcohol Use and Posttraumatic Stress Disorders.
Capone C; Tripp JC; Trim RS; Davis BC; Haller M; Norman SB
J Trauma Stress; 2020 Aug; 33(4):603-609. PubMed ID: 32521096
[TBL] [Abstract][Full Text] [Related]
6. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
[TBL] [Abstract][Full Text] [Related]
7. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
[TBL] [Abstract][Full Text] [Related]
8. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans.
Saraiya TC; Badour CL; Jones AC; Jarnecke AM; Brown DG; Flanagan JC; Killeen TK; Back SE
Psychol Trauma; 2023 Nov; 15(8):1293-1298. PubMed ID: 35025558
[TBL] [Abstract][Full Text] [Related]
9. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.
Gandelman EM; Miller SA; Back SE
J Trauma Stress; 2022 Apr; 35(2):682-693. PubMed ID: 34979039
[TBL] [Abstract][Full Text] [Related]
10. Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders.
Hien DA; Lopez-Castro T; Papini S; Gorman B; Ruglass LM
J Anxiety Disord; 2017 Dec; 52():53-61. PubMed ID: 29049902
[TBL] [Abstract][Full Text] [Related]
11. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.
Fitzpatrick S; Saraiya T; Lopez-Castro T; Ruglass LM; Hien D
J Subst Abuse Treat; 2020 Jun; 113():107976. PubMed ID: 32059924
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders.
Kehle-Forbes SM; Chen S; Polusny MA; Lynch KG; Koffel E; Ingram E; Foa EB; Van Horn DHA; Drapkin ML; Yusko DA; Oslin DW
Drug Alcohol Depend; 2019 Dec; 205():107647. PubMed ID: 31675546
[TBL] [Abstract][Full Text] [Related]
14. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
[TBL] [Abstract][Full Text] [Related]
15. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
[TBL] [Abstract][Full Text] [Related]
16. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
[TBL] [Abstract][Full Text] [Related]
17. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters.
Szafranski DD; Gros DF; Acierno R; Brady KT; Killeen TK; Back SE
Clin Psychol Psychother; 2019 Mar; 26(2):218-226. PubMed ID: 30419153
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
[TBL] [Abstract][Full Text] [Related]
20. Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial.
Meshberg-Cohen S; Cook JM; Bin-Mahfouz A; Petrakis IL
Contemp Clin Trials; 2024 Apr; 139():107475. PubMed ID: 38365173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
